Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice Y Chou

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Nature Reviews. Endocrinology|October 27, 2010
Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapyJanice Y Chou, Hyun Sik Jun, Brian C Mansfield
Molecular Genetics and Metabolism|November 15, 2008
Structure-function study of the glucose-6-phosphate transporter, an eukaryotic antiporter deficient in glycogen storage disease type IbChi-Jiunn Pan, Shih-Yin Chen, Soojung Lee, et al.
Journal of Inherited Metabolic Disease|April 18, 2018
Molecular biology and gene therapy for glycogen storage disease type IbJanice Y Chou, Jun-Ho Cho, Goo-Young Kim, et al.
Molecular Genetics and Metabolism|June 17, 2006
Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patientsAndrew D Nguyen, Chi-Jiunn Pan, David A Weinstein, et al.
Journal of Inherited Metabolic Disease|May 10, 2018
Sirtuin signaling controls mitochondrial function in glycogen storage disease type IaJun-Ho Cho, Goo-Young Kim, Brian C Mansfield, et al.
Biochemical and Biophysical Research Communications|March 17, 2018
Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type IaJun-Ho Cho, Goo-Young Kim, Brian C Mansfield, et al.
Biochemical and Biophysical Research Communications|November 19, 2019
Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type IaJun-Ho Cho, Young Mok Lee, Seong-Ho Bae, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2020
Correction of metabolic abnormalities in a mouse model of glycogen storage disease type Ia by CRISPR/Cas9-based gene editingIrina Arnaoutova, Lisa Zhang, Hung-Dar Chen, et al.
Molecular Genetics and Metabolism|October 7, 2008
Functional analysis of mutations in the glucose-6-phosphate transporter that cause glycogen storage disease type IbShih-Yin Chen, Chi-Jiunn Pan, Soojung Lee, et al.
Journal of Inherited Metabolic Disease|February 5, 2019
An evolutionary approach to optimizing glucose-6-phosphatase-α enzymatic activity for gene therapy of glycogen storage disease type IaLisa Zhang, Jun-Ho Cho, Irina Arnaoutova, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Nature Reviews. Endocrinology|October 27, 2010
Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapyJanice Y Chou, Hyun Sik Jun, Brian C Mansfield
Molecular Genetics and Metabolism|November 15, 2008
Structure-function study of the glucose-6-phosphate transporter, an eukaryotic antiporter deficient in glycogen storage disease type IbChi-Jiunn Pan, Shih-Yin Chen, Soojung Lee, et al.
Journal of Inherited Metabolic Disease|April 18, 2018
Molecular biology and gene therapy for glycogen storage disease type IbJanice Y Chou, Jun-Ho Cho, Goo-Young Kim, et al.
Molecular Genetics and Metabolism|June 17, 2006
Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patientsAndrew D Nguyen, Chi-Jiunn Pan, David A Weinstein, et al.
Journal of Inherited Metabolic Disease|May 10, 2018
Sirtuin signaling controls mitochondrial function in glycogen storage disease type IaJun-Ho Cho, Goo-Young Kim, Brian C Mansfield, et al.
Biochemical and Biophysical Research Communications|March 17, 2018
Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type IaJun-Ho Cho, Goo-Young Kim, Brian C Mansfield, et al.
Biochemical and Biophysical Research Communications|November 19, 2019
Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type IaJun-Ho Cho, Young Mok Lee, Seong-Ho Bae, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2020
Correction of metabolic abnormalities in a mouse model of glycogen storage disease type Ia by CRISPR/Cas9-based gene editingIrina Arnaoutova, Lisa Zhang, Hung-Dar Chen, et al.
Molecular Genetics and Metabolism|October 7, 2008
Functional analysis of mutations in the glucose-6-phosphate transporter that cause glycogen storage disease type IbShih-Yin Chen, Chi-Jiunn Pan, Soojung Lee, et al.
Journal of Inherited Metabolic Disease|February 5, 2019
An evolutionary approach to optimizing glucose-6-phosphatase-α enzymatic activity for gene therapy of glycogen storage disease type IaLisa Zhang, Jun-Ho Cho, Irina Arnaoutova, et al.
Pageof 6